Janelle M. Ramsahai

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.

Journal: Nature communications
Published: March 08, 2025

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 28, 2023

Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.

Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.

Journal: Gynecologic oncology
Published: May 12, 2022

Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.

Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.

Journal: Thorax
Published: July 01, 2021

Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma.

Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma.

Journal: BMC pulmonary medicine
Published: April 20, 2020

A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?

A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?

Journal: ERJ open research
Published: March 07, 2020

Does prior mediastinal lymph node aspiration contribute to false-positive positron emission tomography-computed tomography?

Does prior mediastinal lymph node aspiration contribute to false-positive positron emission tomography-computed tomography?

Journal: ERJ open research
Published: February 28, 2020

Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221.

Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 01, 2019

Mechanisms and Management of Asthma Exacerbations.

Mechanisms and Management of Asthma Exacerbations.

Journal: American journal of respiratory and critical care medicine
Published: December 19, 2018

A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium.

A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 22, 2018

Appropriate use of oral corticosteroids for severe asthma.

Appropriate use of oral corticosteroids for severe asthma.

Journal: The Medical journal of Australia
Published: February 06, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026